IL93986A0 - Improvements in and relating to pharmaceutical formulations - Google Patents

Improvements in and relating to pharmaceutical formulations

Info

Publication number
IL93986A0
IL93986A0 IL93986A IL9398690A IL93986A0 IL 93986 A0 IL93986 A0 IL 93986A0 IL 93986 A IL93986 A IL 93986A IL 9398690 A IL9398690 A IL 9398690A IL 93986 A0 IL93986 A0 IL 93986A0
Authority
IL
Israel
Prior art keywords
relating
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
IL93986A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL93986A0 publication Critical patent/IL93986A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44Antibodies bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL93986A 1989-04-04 1990-04-02 Improvements in and relating to pharmaceutical formulations IL93986A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33315489A 1989-04-04 1989-04-04

Publications (1)

Publication Number Publication Date
IL93986A0 true IL93986A0 (en) 1991-01-31

Family

ID=23301547

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93986A IL93986A0 (en) 1989-04-04 1990-04-02 Improvements in and relating to pharmaceutical formulations

Country Status (8)

Country Link
EP (1) EP0392717A1 (hu)
JP (1) JPH02290822A (hu)
KR (1) KR900015760A (hu)
AU (1) AU5252090A (hu)
CA (1) CA2013600A1 (hu)
HU (1) HUT54308A (hu)
IL (1) IL93986A0 (hu)
ZA (1) ZA902519B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9418092D0 (en) * 1994-09-08 1994-10-26 Red Cross Found Cent Lab Blood Organic compounds
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
TWI398272B (zh) 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
US7705132B2 (en) 2006-10-20 2010-04-27 Amgen Inc. Stable polypeptide formulations
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
ES2716088T3 (es) 2010-02-04 2019-06-10 Csl Behring Ag Preparado de inmunoglobulina
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1254057A (en) * 1969-04-24 1971-11-17 Louisette Olivier Improvements in or relating to therapeutical composition containing vincamine
IL82579A0 (en) * 1986-05-27 1987-11-30 Lilly Co Eli Immunoglobulin conjugates
ZA89524B (en) * 1988-01-27 1990-09-26 Lilly Co Eli Antibody conjugates
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation

Also Published As

Publication number Publication date
AU5252090A (en) 1990-10-11
EP0392717A1 (en) 1990-10-17
ZA902519B (en) 1991-12-24
HU902047D0 (en) 1990-08-28
HUT54308A (en) 1991-02-28
CA2013600A1 (en) 1990-10-04
KR900015760A (ko) 1990-11-10
JPH02290822A (ja) 1990-11-30

Similar Documents

Publication Publication Date Title
GB2225764B (en) Improvements in and relating to drug capsules
AU5561690A (en) Improvements in or relating to pharmaceutical preparations
GB9001607D0 (en) Improvements in and relating to packaging
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
GB2235910B (en) Improvements in and relating to conveying
GB8925555D0 (en) Improvements in and relating to tents
IL93986A0 (en) Improvements in and relating to pharmaceutical formulations
IL93252A0 (en) Improvements in and relating to guanidine derivatives
GB8901722D0 (en) Improvements in and relating to pillows
AU7008687A (en) Improvements in and relating to vaccines
GB2227774B (en) Improvements in and relating to bridges
AU3275489A (en) Improvements in or relating to pharmaceutical compounds and compositions
GB2237222B (en) Improvements in and relating to pulverisers
GB8919132D0 (en) Improvements in and relating to display devices
GB8924503D0 (en) Improvements in and relating to duckboards
GB9024556D0 (en) Improvements in and relating to display devices
GB8912243D0 (en) Improvements in and relating to bollards and similar structures
GB8909445D0 (en) Improvements in and relating to umbrellas
GB8925284D0 (en) Improvements in and relating to disinfectants
GB2227443B (en) Improvements in and relating to packaging
GB8904342D0 (en) Improvements in and relating to cots
GB8900160D0 (en) Improvements in and relating to harvesters
GB8918946D0 (en) Improvements in and relating to dolls
GB8921761D0 (en) Improvements in and relating to packaging
GB8900416D0 (en) Improvements in and relating to packaging